pentobarbital has been researched along with Syndrome in 3 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
Syndrome: A characteristic symptom complex.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kontogiorgi, M | 1 |
| Opsimoulis, P | 1 |
| Diamanti-Kandarakis, E | 1 |
| Karabinis, A | 1 |
| Ahern, CP | 1 |
| Somers, CJ | 1 |
| Wilson, P | 1 |
| McLoughlin, JV | 1 |
| Karpathios, T | 1 |
| Zervoudakis, A | 1 |
| Venieris, F | 1 |
| Parchas, S | 1 |
| Youroukos, S | 1 |
3 other studies available for pentobarbital and Syndrome
| Article | Year |
|---|---|
Cerebral salt wasting syndrome in traumatic brain injury following therapeutic barbiturate coma.
Topics: Brain Injuries; Coma; Humans; Hypnotics and Sedatives; Hyponatremia; Inappropriate ADH Syndrome; Int | 2011 |
Halothane-induced malignant hyperthermia: creatine phosphate concentration in skeletal muscle as an early indicator of the onset of the syndrome.
Topics: Adenosine Triphosphate; Anesthesia, Intravenous; Animals; Glucosephosphates; Halothane; Lactates; Ma | 1980 |
Genetics and fetal hydantoin syndrome.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Anticonvulsants; Child; Child, Preschoo | 1989 |